Gary Goldenberg's Insider Trades & SAST Disclosures
Gary Goldenberg's most recent trade in Verrica Pharmaceuticals Inc was a trade of 9,888 Common Stock done at an average price of $2.7 . Disclosure was reported to the exchange on Aug. 26, 2024.
Add Superstar Alert
Note
This is a custom search result for pattern Gary Goldenberg.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Verrica Pharmaceuticals Inc
High Loss High Volume |
Gary Goldenberg | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.66 per share. | 26 Aug 2024 | 9,888 | 97,862 (0%) | 0% | 2.7 | 26,302 | Common Stock |
|
Verrica Pharmaceuticals Inc
High Loss High Volume |
Gary Goldenberg | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.46 per share. | 26 Aug 2024 | 3,601 | 94,261 (0%) | 0% | 2.5 | 8,858 | Common Stock |
|
Verrica Pharmaceuticals Inc
High Loss High Volume |
Gary Goldenberg | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 7.06 per share. | 22 Jul 2024 | 18,421 | 107,836 (0%) | 0% | 7.1 | 130,052 | Common Stock |
|
Verrica Pharmaceuticals Inc
High Loss High Volume |
Gary Goldenberg | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.98 per share. | 22 Jul 2024 | 86 | 107,750 (0%) | 0% | 7.0 | 600 | Common Stock |
|
Verrica Pharmaceuticals Inc
High Loss High Volume |
Gary Goldenberg | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 80,000 | 80,000 | - | - | Employee Stock Option (right to buy) | |
|
Verrica Pharmaceuticals Inc
High Loss High Volume |
Gary Goldenberg | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 40,000 | 126,257 (0%) | 0% | 0 | Common Stock | |
|
Verrica Pharmaceuticals Inc
High Loss High Volume |
Gary Goldenberg | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.93 per share. | 14 Nov 2023 | 5,817 | 89,293 (0%) | 0% | 2.9 | 17,044 | Common Stock |
|
Verrica Pharmaceuticals Inc
High Loss High Volume |
Gary Goldenberg | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.97 per share. | 14 Nov 2023 | 3,036 | 86,257 (0%) | 0% | 3.0 | 9,017 | Common Stock |
|
Verrica Pharmaceuticals Inc
High Loss High Volume |
Gary Goldenberg | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Aug 2023 | 50,000 | 120,110 (0%) | 0% | 0 | Common Stock | |
|
Verrica Pharmaceuticals Inc
High Loss High Volume |
Gary Goldenberg | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Aug 2023 | 25,000 | 95,110 (0%) | 0% | 0 | Common Stock | |
|
Verrica Pharmaceuticals Inc
High Loss High Volume |
Gary Goldenberg | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 75,000 | 98,809 (0%) | 0% | 0 | Common Stock | |
|
Verrica Pharmaceuticals Inc
High Loss High Volume |
Gary Goldenberg | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 4.83 per share. | 21 Jul 2023 | 28,699 | 70,110 (0%) | 0% | 4.8 | 138,616 | Common Stock |
|
Verrica Pharmaceuticals Inc
High Loss High Volume |
Gary Goldenberg | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 85,000 | 85,000 | - | - | Employee Stock Option (right to buy) | |
|
Verrica Pharmaceuticals Inc
High Loss High Volume |
Gary Goldenberg | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 2.10 per share. | 05 Jul 2022 | 23,809 | 23,809 (0%) | 0% | 2.1 | 49,999 | Common Stock |
|
Verrica Pharmaceuticals Inc
High Loss High Volume |
Gary Goldenberg | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 65,000 | 65,000 | - | - | Employee Stock Option (Right to Buy) | |
|
Verrica Pharmaceuticals Inc
High Loss High Volume |
Gary Goldenberg | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2020 | 250,000 | 250,000 | - | - | Employee Stock Option (right to buy) | |
|
Verrica Pharmaceuticals Inc
High Loss High Volume |
Gary Goldenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 5,834 | 5,834 | - | - | Option Grant (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges